logo
Plus   Neg
Share
Email

Alexion Pharma Raises 2019 Outlook

Alexion Pharmaceuticals Inc. (ALXN) increased its revenues and earnings per share guidance for fiscal year 2019.

The company raised its fiscal year 2019 earnings per share outlook to a range of $8.58 to $8.78 from the prior estimation of $8.13 to $8.41 per share. It also increased its non-GAAP earnings per share guidance to a range of $10.25 to $10.40 from the previous outlook of $9.65 to $9.85 per share. Analysts polled by Thomson Reuters expect the company to report earnings of $9.94 per share for fiscal year 2019. Analysts' estimates typically exclude special items.

The company now projects total revenues for fiscal year 2019 to be $4.860 billion to $4.890 billion, compared to the prior outlook of $4.750 billion to $4.800 billion. Analysts expect revenues of $4.85 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Airbnb has introduced few new rules to control parties and nuisances amidst the backlash the service received after the Halloween shooting at an Airbnb rental in a San Francisco. San Francisco-based Airbnb said it is banning "open invite" parties at all of its accommodations. The company is also banning... The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director... Shares of Upscale furniture chain RH (RH) are on a tear, on the heels of an upbeat annual forecast. Today, the stock set a new all-time high of $239.88.The stock is up more than 20% from its Dec 3 opening price of $196.66, and currently trading at $237.8, and nearly three-times its 52-week low of $84.11....
Follow RTT
>